Dorothy Lou Bailey

The Reckon Group

Dorothy Lou advises Indie Bio entrepreneurs on business and commercialization strategies leveraging more than a decade in the life science industry. Currently, Dorothy Lou leads BD at Transcriptic and where she has brokered strategic partnerships across industries and government organizations.  She has advised companies out of Y-Combinator, QB3, Rock Health, Janssen Labs, and Stanford Biodesign in addition to being a founder herself.  Dorothy Lou graduated with distinction from Duke University with a BS in Molecular Biology & Biochemistry.

Be Part of the Revolution!

Next program starts Winter 2017. Applications due October 30th!